Brain Blood Flow and Lactate in Non-obese and Obese Subjects
Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Jan 19, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a substance called lactate, which the body produces during exercise, affects blood flow to the brain in people with and without obesity. Researchers want to understand if higher levels of lactate can improve brain health and function, especially since reduced blood flow to the brain can lead to serious issues like memory loss and conditions such as Alzheimer’s disease. The trial will also explore if short exercise sessions can help people with obesity manage their lactate levels better.
To be eligible for this study, participants should be healthy adults aged 18 to 45, with a body mass index (BMI) between 18 and 40. Women must be premenopausal and not pregnant or breastfeeding. There are some health conditions, medications, and recent health events that could prevent someone from participating, so it’s important for potential volunteers to discuss their health history with the researchers. If chosen, participants can expect to take part in exercises and tests that will help scientists learn more about the relationship between lactate, exercise, and brain blood flow.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy adult men and women 18-45 years of age BMI 18-40 kg/m2 not pregnant, premenopausal with regular menstrual cycles not breastfeeding non-nicotine users
- Exclusion Criteria:
- • medications known to affect sleep, autonomic control, blood lactate levels or metabolic, or cardiovascular function (PI discretion) self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse major cardiovascular event or surgical procedure within the past three months hypertension (\>140/90 mmHg or at PIs discretion).
- • -
About University Of Missouri Columbia
The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Trial Officials
Jill Kanaley, PhD
Principal Investigator
University of Missouri-Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported